65,437 trials
Atopic Dermatitis
Primary: Percent Change in Eczema Area and Severity Index (EASI) Score — -61.15; -57.05; -64.27; -51.42 percent of change — p=0.0090
Infertility, Female
Primary: Number of Oocytes Retrieved — 12.7; 11.8 Oocytes retrieved
Monkeypox
Primary: Frequency of SAEs After First Dose of MVA-BN Vaccine — 0 Participants
Trigger Point Pain, Myofascial
Primary: Pain Scores on the Visual Analog Scale — 51; 55; 40; 42 Pain Scores on the Visual Analog Scale
Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma · Head and Neck Carcinoma
Primary: Rate of Dose Limiting Toxicity (DLT) — 1 Participants
Amputation · Prosthesis User
Primary: Vertical Ground Reaction Force Impulse (Normalized) — 5.24; 5.30; 5.27; 5.33 Newtons*seconds/kg — p=0.100
Mother to Child Transmission · Pregnancy in Adolescence · Social Stigma
Primary: User Version Mobile Application Rating Scale (uMARS) - Objective Quality Measure — 4.81 score on a scale
Prostate Cancer
Primary: Number of Participants With Treatment-emergent Adverse Events as Classified by MedDRA — 2; 2; 1; 2 Participants
Chronic Kidney Diseases
Primary: Change From Baseline in eGFR at 6 Months (Patient-specific) — -2.35; -4.24 mL/min/1.73m^2
Facial Injuries
Primary: Change in the Facial Range of Motion at Baseline and Week 8 — -16.12; -.08; -7.34; 4.47 mm
Influenza A
Primary: Magnitude of Antibody Response After the Late-season 2023 Vaccine — 6; 6; 74; 27 HAI Titer
Amputation · Amputation; Postoperative, Sequelae · Wound Dehiscence
Primary: Overall Rate of Wound Complications — 26; 31 Participants
Obesity · Energy Balance · Appetite
Primary: Appetite- Subjective — 6282; 8738 score*minute
Glucose · Circadian Rhythm · Melatonin
Primary: Disposition Index — 1314.7; 984.5 index
Temperature
Primary: Temperature Comparison — -0.60; -0.24; -0.16; -0.19 Degree Celsius